When was Otogenetics founded?

Otogenetics was founded in 2007 and raised its 1st funding round 2 years after it was founded.

Where is Otogenetics located?

Otogenetics is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia.

How many employees does Otogenetics have?

As of Apr 30, 2026, the latest employee count at Otogenetics is 41.

Is Otogenetics a funded company?

Otogenetics is a funded company, having raised a total of $***** in its 1st and only funding round, a Grant (prize money) round on Sep 16, 2009.

When was the latest funding round of Otogenetics?

Otogenetics' latest funding was a $***** Grant (prize money) round on Sep 16, 2009, with participation from 1 investor.

Where does Otogenetics rank among its competitors?

Otogenetics ranks 85th amongst 646 active competitors, of which 75 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Eclipse Bio, which secured $4.91M in Nov, 2025.

Who are the top competitors of Otogenetics?

Otogenetics' top competitors include Illumina, Strand Life Sciences and Arbor Biotechnologies. Among them, Eclipse Bio secured the most recent funding round in November, 2025.

Otogenetics - 2026 Company Profile, Funding & Competitors

Otogenetics is a funded company based in Atlanta (United States), founded in 2007. It operates as a Provider of the next-generation sequencing platform for genetic testing. Otogenetics has raised an undisclosed amount in funding. The company has 646 active competitors, including 75 funded and 77 that have exited. Its top competitors include companies like Illumina, Strand Life Sciences and Arbor Biotechnologies.

Company Details

Provider of the next-generation sequencing platform for genetic testing. The company offers services such as human, mouse exome sequencing, RNA sequencing, mitochondrial genome sequencing, disease panels for breast cancer genes, cardiomyopathy, colorectal cancer, etc. It also provides disease panel services (clinical) for breast cancer, deafness, inherited cancer. Also, it offers products and reagents such as DNA Library, preparation kits, whole mitochondrial DNA NGS Deep sequencing kits, and more

Website: www.otogenetics.com/
Social
Registered Address: Atlanta, Georgia

Key Metrics

Founded Year

2007

Location

Atlanta, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Sep 16, 2009, $*****

Investors

NIH & 1 more

Ranked

85^th among 646 active competitors

Employee Count

41 as on Apr 30, 2026

Similar Companies

Illumina & 801 more

View Otogenetics' full profile

Otogenetics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
OTOGENETICS CORPORATION 401K PLAN CIN: 261343895 , United States, Active	Dec 31, 1999	-	33 (As on Dec 31, 2024)	-

Otogenetics has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Sep 16, 2009 for $*****. 1 investor participated in its latest round. Otogenetics has 2 institutional investors.

Here is the list of recent funding rounds of Otogenetics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 16, 2009	4166353	Grant (prize money)	6274015	8236926	2465168	1775455

Access funding benchmarks and valuations. Sign up today!

View details of Otogenetics's funding rounds and investors

Otogenetics' employee count trend

Otogenetics has 41 employees as of Apr 26. Here is Otogenetics's employee count trend over the years:

Uncover Otogenetics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Otogenetics include Illumina, Strand Life Sciences and Arbor Biotechnologies. Here is the list of Top 10 competitors of Otogenetics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	State Farm, Chevron Technology Ventures & 32 others	80/100
2nd	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, Quadria Capital & 91 others	72/100
3rd	Arbor Biotechnologies 2016, Cambridge (United States), Series C	Provider of genomic technologies and drug discovery platform	$304M	TCG Crossover, Ally Bridge Group & 26 others	65/100
4th	MGI 2016, Shenzhen (China), Series B	Provider of gene sequencing instruments, reagents, equipment, and related products	$1B	Guotai Junan Securities, CoStone Capital ... & 11 others	64/100
5th	Eclipse Bio 2017, San Diego (United States), Series A	Developer of cell-free immunoassay	$18.9M	Alexandria, IGlobe Partners & 2 others	63/100
6th	Novogene Corporation 2011, Beijing (China), Series B	Provider of genomic services and solutions	$75M	SDIC Innovation, CMB International Capital ... & 4 others	61/100
7th	ONCOHOST 2017, Binyamina Giv at Ada (Israel), Series C	AI-based oncology therapy plan solution for professionals	$43M	OurCrowd, ALIVE & 5 others	61/100
8th	Singleron 2018, Hagen (Germany), Series B	Developer of single-cell multi-omics platform for clinical research and molecular diagnosis	$84.5M	Yuanhe Holdings, Frees Fund & 13 others	59/100
9th	Genewiz 1999, South Plainfield (United States), Acquired	Provider of a wide range of genomic services for the life sciences industry	-	Orbimed, Kenson Ventures & 5 others	59/100
10th	deCODE Genetics 1996, Reykjavik (Iceland), Acquired	Provider of a bioinformatics platform for genetic analysis	-	Polaris Partners, Tekla Capital Management ... & 10 others	59/100
85th	Otogenetics 2007, Atlanta (United States), Funding Raised	Provider of the next-generation sequencing platform for genetic testing	-	NIH, HHS	32/100